Register

Powered By: Explore the Capabilities of Dexcom G6 Integrated CGM (iCGM)

ATDC Conference
Thursday, July 15, 2021
5:00 PM – 6:15 PM MT

Join us for a robust overview of the possibilities of interoperability with the Dexcom G6 iCGM System. Take a deep dive into iCGM and its role in diabetes management. This presentation will provde a comprehensive overview of Dexcom G6 unique features and functionality, and provide the latest clinical evidence around the use of Dexcom CGM. Learn more about Dexcom’s vision for patient empowerment through strategic partnerships. Hear the latest updates on product integrations with automated insulin delivery systems, connected insulin pens and digital health apps.

Dr. Sushma Reddy, MD
Endocrinologist, Steady Health

Dr. Greg Forlenza, MD
University of Colorado Hospital, Barbara Davis Center for Childhood Diabetes

Kevin Sayer
Chairman, President & Chief Executive Officer, Dexcom

Cher Pastore, MS, RD, CDE
Clinical Education, Dexcom

BRIEF SAFETY STATEMENT

Failure to use the Dexcom G6 Continuous Glucose Monitoring System (G6) and its components according to the instructions for use provided with your device and available at https://www.dexcom.com/safety-information and to properly consider all indications, contraindications, warnings, precautions, and cautions in those instructions for use may result in you missing a severe hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose) occurrence and/or making a treatment decision that may result in injury. If your glucose alerts and readings from the G6 do not match symptoms or expectations or you’re taking over the recommended maximum dosage amount of 1000mg of acetaminophen every 6 hours, use a blood glucose meter to make diabetes treatment decisions. Seek medical advice and attention when appropriate, including for any medical emergency.